Intranasal delivery of biologically active lipid messengers halts memory loss and neurodegeneration in mouse models of Alzheimer's disease.
Treatment with LAU-0901, a synthetic molecule that blocks pro-inflammatory platelet-activating factor, in addition to aspirin-triggered NPD1, reduced the size of damage areas in the brain, initiated repair mechanisms, and improved behavioral recovery following ischemic stroke.
Researchers shed new light on how DHA, a key essential Omega-3 fatty acid, could help promote cell survival and contribute to treating Alzheimer's, Parkinson's disease and stoke.
A new study reports a molecule made from DHA can trigger the production of a protein that protects against free radicals.
